0 comments

We’re pleased to announce that CredibleMeds was recently cited in two major scientific publications of practice guidelines for cardiologists.

View Post

0 comments

mobile_photo

QTdrugs lists now can be filtered by market status in US vs non-US

View Post

0 comments

mobile_photo

Inotuzumab, benperidol, betrixaban and Clofazimine added, famotidine moved to Conditional Risk

View Post

0 comments

mobile_photo

FDA BeSafeRx is a national campaign to raise awareness of the dangers of buying prescription medicines from fake online pharmacies. This campaign provides the resources to help consumers.

View Post

0 comments

mobile_photo

The CredibleMeds online QTdrugs list was recently applied in a study carried out in Denmark to evaluate the association between use of medications on sudden cardiac death (SCD). With a sharp increase in the number of prescribed drugs to the general population over the past decade, researchers sought to examine whether there is a significant correlation between multiple prescription drug use and SCD.

View Post

0 comments

AZCERT, sponsor of CredibleMeds, is delighted to announce the addition of two new members to our Board of Directors. Doctors Jim Galloway and Jim Tisdale bring talent and broad expertise to the Board of AZCERT and CredibleMeds. For more information on the extraordinary stories of our newest leaders.

View Post

3 comments

mobile_photo

We’re excited to announce that CredibleMeds was recently featured as a trusted, informative resource in a recent article published in P&T Community’s Pharmacovigilance Forum. The article focuses on the many common medicines that may increase the risk of drug-induced QT Prolongation and Torsades de Pointes arrhythmia

View Post

0 comments

mobile_photo

Four New Drug Added to CredibleMeds® Lists and Mobile Apps for QTdrugs/DTA Lists

View Post


1 comment

mobile_photo

Because the safe use of the CredibleMeds® lists of medications requires that the user have the most up-to-date lists of drugs, we are informing you of these changes to the QTdrugs.org lists: 1. Add Ribociclib and Necitumumab to Possible Risk List 2. Remove Foscarnet from Possible Risk List

View Post